《半日总结》恒指升189点 内银内险领涨 建行扬4%
美国总统特朗普表示会接受规模逾1.8万亿美元的新刺激经济方案，市场重燃对新刺激方案憧憬。港股昨(15日)跌逾500点後今早乘势反弹。恒指高开35点後升幅扩大，曾升277点见24,436点，半日升189点或0.8%，报24,347点；国指升124点或1.3%，报9,887点；恒生科技指数升24点或0.3%，报7,565点。大市半日成交总额626.31亿元，沪、深港通南下交易半日录得净流入金额分别为19.16亿及13.09亿元人民币。
内银及内银股领涨，内银股建行(00939.HK)及工行(01398.HK)各升4%及3.3%，农行(01288.HK)及中行(03988.HK)各升2.7%及2%，邮储行(01658.HK)及招行(03968.HK)各升6.6%及3.9%，民行(01988.HK)、交行(03328.HK)及中信银行(00998.HK)各升3.4%至3.5%。大和发表报告指人行允宏观杠杆率暂时上升，信贷条件利内银股。
内险股人保(01339.HK)及财险(02328.HK)股价均升3%，新华保险(01336.HK)及太保(02601.HK)各升3.7%及3.8%，中国太平(00966.HK)及国寿(02628.HK)各升2.5%及2.6%，中国平安(02318.HK)升1%。
主要科网股普遍回稳，腾讯(00700.HK)升0.6%报555.5元，阿里巴巴(09988.HK)升2.3%报291.4元，小米(01810.HK)升2.9%报23.1元，美团(03690.HK)升0.2%报265.6元，京东(09618.HK)跌0.2%，网易(09999.HK)升0.7%。
汽车股方面，比亚迪(01211.HK)回吐5.2%，吉利(00175.HK)跌2.4%，长城汽车(02333.HK)则升2.9%。医药股个别发展，中国工程院院士钟南山指，研究发现白云山(00874.HK)复方板蓝根颗粒对新冠病毒有效，白云山股价急弹12.8%。威高(01066.HK)及信达生物(01801.HK)各升4.4%及2.9%。石药(01093.HK)则跌5%，
体育用品股普遍上升，李宁(02331.HK)及滔搏(06110.HK)各升2.6%及2%，特步(01368.HK)急升9.2%。
其余蓝筹股方面，汇控(00005.HK)升0.3%报30元，港交所(00388.HK)跌0.2%报361.4元，友邦(01299.HK)升0.2%报78.5元，中移动(00941.HK)升0.1%报50.3元，中信股份(00267.HK)升2.7%报5.78元。
上海集优(02345.HK)获上海电气(02727.HK)提出以每股H股1.6元私有化，股价急升57.9%报1.5元。金风科技(02208.HK)连日炒作国策利好後回吐，半日跌10.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
